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Abstract
Summary Areal bone mineral density (aBMD) predicts future
fracture risk. This study explores the development of aBMD
and associated factors in Norwegian adolescents. Our results
indicate a high degree of tracking of aBMD levels in adoles-
cence. Anthropometric measures and lifestyle factors were
associated with deviation from tracking.
Purpose Norway has one of the highest reported incidences of
hip fractures. Maximization of peak bone mass may reduce fu-
ture fracture risk. The main aims of this study were to describe
changes in bone mineral levels over 2 years in Norwegian ado-
lescents aged 15–17 years at baseline, to examine the degree of
tracking of aBMD during this period, and to identify baseline
predictors associated with positive deviation from tracking.
Methods In 2010–2011, all first year upper secondary school
students in Tromsø were invited to the Fit Futures study and
1038 adolescents (93%) attended. We measured femoral neck
(FN), total hip (TH), and total body (TB) aBMD as g/cm2 by
DXA. Two years later, in 2012–2013, we invited all participants
to a follow-up survey, providing 688 repeated measures of
aBMD.
Results aBMD increased significantly (p < 0.05) at all skeletal
sites in both sexes.Mean annual percentage increase for FN, TH,
and TBwas 0.3, 0.5, and 0.8 in girls and 1.5, 1.0, and 2.0 in boys,
respectively (p < 0.05). There was a high degree of tracking of
aBMD levels over 2 years. In girls, several lifestyle factors pre-
dicted a positive deviation from tracking, whereas anthropomet-
ric measures appeared influential in boys. Baseline z-score was
associated with lower odds of upwards drift in both sexes.
Conclusions Our results support previous findings on aBMD
development in adolescence and indicate strong tracking over
2 years of follow-up. Baseline anthropometry and lifestyle
factors appeared to alter tracking, but not consistently across
sex and skeletal sites.
Keywords Bonemass . Bone development . Tracking .
Adolescence . Areal bonemineral density . DXA
Introduction
Norway has one of the highest reported incidences of hip frac-
tures [1]. Areal bone mineral density (aBMD) is strongly associ-
ated with fracture risk. aBMD levels in the elderly are a result of
peak bone mass (PBM) achieved during growth and subsequent
bone loss [2]. Adolescence is characterized by massive skeletal
changes due to rapid modeling and remodeling [3]. About 40%
of bone mass are accumulated around the 4 years of peak height
velocity (PHV) during puberty and about 90% by the age of 18
[4, 5]. These rapid changes generate both opportunities and vul-
nerabilities related to future bone health. Previous studies indicate
that one standard deviation increase in bone mass at the end of
skeletal maturation decrease future fracture risk by as much as
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50% [4]. This makes maximization of the genetic potential for
bone mass acquisition a strategy for prevention of osteoporosis
and fragility fractures later in life. The clinical importance of this
concept depends on the degree of tracking or stability of bone
mineral status from younger years into adulthood [6]. Early pre-
ventive measures can be employed if there is a high correlation
between bone mass levels in the younger years and later in life.
Studies report that high aBMD in athletes or low aBMD due to
deficits may persist into adulthood [7, 8]. Previous population-
based longitudinal studies demonstrate strong tracking of aBMD
from childhood to skeletal maturity [9–13]. The degree of track-
ing from adolescence into adulthood is, however, unclear
[14–16]. Potential variation in tracking into adulthood and incon-
sistent evidence [10–12] calls for attention to predictors of devi-
ation from tracking in late adolescence. The objectives of this
population based longitudinal study were (1) to describe the
changes in bone traits over 2 years in Norwegian adolescents
aged 15–19 years, (2) to explore tracking of aBMD status over
2 years, and (3) to identify baseline anthropometric measures and
lifestyle factors associated with deviation from tracking. It is our
hypothesis that participants mainly remain in their original
aBMD quartile between the ages of 15 and 19 years of age and




The Tromsø Study is an ongoing population-based epidemio-
logical study with seven repeated surveys conducted among the
adult population since 1974 [17]. As part of the Tromsø Study,
Fit Futures invited all first year upper secondary school students
in Tromsø and the neighboring municipalities to a comprehen-
sive health survey in 2010–2011 (TFF1, baseline). The invited
cohort comprised 1117 adolescents and 1038 (508 girls and 530
boys) attended the survey (attendance rate 93%). Among those,
95% of the participants were in the range between 15 and
18 years of age. Two years later, in 2012–2013, all third year
upper secondary school students in the same schools and all
TFF1 participants not attending school at that time were invited
to a follow-up survey, Fit Futures 2 (TFF2). In total, 820 ado-
lescents attended, providing 688 repeated measures of aBMD
(66% of the TFF1 cohort) (Fig. 1). The Clinical Research Unit
at the University Hospital of North Norway conducted both
surveys during school days. The Regional Committee of
Medical Research Ethics approved the study (Ref.
2013/1459/REK nord). The study protocol for TFF1 was ap-
proved by The Norwegian Data Inspectorate 27.07.2010 (Ref.
07/00886-7/CGN) and the Regional Committee for Medical
Research Ethics (REK-Nord) 16.09.2010 (Ref. 2009/1282-
23). The study protocol for TFF2 was approved as an extension
of the prior approval by the Data Inspectorate 31.10.2012 (Ref.
07/00886-15/EOL). All participants gave written informed
consent. Participants below 16 years of age had to bring written
consent from their superiors to attend the survey.
Measurements
We measured total body (TB), total hip (TH), and femoral
neck (FN), bone mineral content (BMC; g), bone area (BA;
cm2), and aBMD (g/cm2) by DXA (GE Lunar prodigy) and
performed analyses by Encore pediatric software [18]. The
densitometer coefficient of variation (CV = [SD/mean] ×
100) has been estimated to 1.14% at the total hip measured
in vivo [19]. We used the same densitometer in both surveys,
and no densitometer drift was detected between the surveys.
Trained technicians performed the measurements, and the
quality assessment was done according to the same protocol
in both surveys. We used measurements of left hip at both
femoral sites. In 15 cases, left hip data was missing and the
right hip was used. Measurements from the same hip were
used in both TFF1 and TFF2. Height and weight were mea-
sured to the nearest 0.1 cm and 0.1 kg on the same electronic
scale in both surveys (Dong Sahn Jenix, Korea), with partic-
ipants wearing no shoes and light clothing. We assessed use of
medication, acute and chronic diseases, hormonal contracep-
tive use, and the possibility of pregnancy by clinical inter-
views, and pregnant participants were excluded from DXA
scanning. Participant’s answers on diseases and use of medi-
cation known to affect bone were operationalized into dichot-
omous variables. Hormonal contraceptive use were catego-
rized into no use, combined estrogen and progestogen-based
contraceptive (CHC) use, and progestogen-only contraceptive
use. We collected sexual maturation information by self-
administered questionnaires. In girls, pubertal status was de-
termined through the following questions: “If you have started
menstruating, how old were you when you had your first
menstruation.” Answers were categorized into “early”
(<12.5 years at menarche), “intermediate” (12.5–13.9 years),
or “late” (>14 years) sexual maturation. Boys were examined
according to Pubertal Developmental Scale (PDS). The boys
self-rated secondary sexual characteristics as growth spurt,
pubic hair growth, changes in voice, and facial hair growth
on a scale from 1 (have not begun) to 4 (completed). We
summarized the score and divided by 4. We categorized a
score <2 as “have not begun,” 2–2.9 as “barely started,” 3–
3.9 as “underway,” and a score of 4 as “completed” [20]. The
participants were asked to grade leisure time physical activity
(PA) in an average week during the last year according to a
four-level scale, which are sedentary activities only; moderate
activity like walking, cycling, or exercise at least 4 h per week;
participation in recreational sports at least 4 h per week; or
participation in hard training/sports competitions several times
a week. This question was developed by Saltin and Grimby
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[21] and has previously been validated in the Tromsø Study
[22]. Questions on smoking and snuffing had the following
three alternatives: never, sometimes, or daily, while frequency
of alcohol consumption had the following five alternatives:
“never,” “once per month or less,” “two to four times per
month,” “two to three times per week,” and “four or more
times per week.” We dichotomized answers on smoking,
snuffing, and alcohol into yes and no.
Statistical analyses
All analyses were performed sex stratified. We calculated means
and standard deviations for continuous variables and percentage
for categorical variables to describe the study population charac-
teristics. Differences in anthropometric and DXA measures be-
tween FF1 andTFF2were tested using paired sample t test, while
dichotomous lifestyle factors were tested with McNemar’s test.
We explored differences between participants and non-
responders in TFF2 using Student’s t test and chi-squared testing.
Average absolute change and percentage change for BMC and
aBMD for each skeletal site were calculated by the difference
between the measurements (T2 − T1). We used exact measure-
ment dates to compute annual change to account for differences
in time between measurements. We stratified participants by age
and used one-way ANOVA and multiple comparisons with
Bonferroni post hoc test to examine differences in mean aBMD
change between groups. We calculated individual age and sex-
specific height, weight, FN, TH, and TB aBMD and BMC z-
scores (standard deviations away from the sample specific mean)
and examined correlations between baseline and follow-up using
Pearson’s correlation coefficient. Because height and weight are
known determinants of aBMD and the adjustment for height in
1301 Registered students for first year 
upper secondary school 2010/11. 
1117 was invited to FF1. 
1038 participated FF1. 508 girls and 530 
boys. 
All third upper secondary school students 
year 2012/13 were invited to FF2, including 
all participants of FF1. 820 participated in 
FF2. 132 new cases with only FF2 data 
184 either dropped out of school before 
study started, or we were unable to contact 
or had persistent disease. 
79 did not attend the FF1 survey. 
34 participants over 18 years of age 
350 lost to follow-up 
688 repeated measures (66% of the FF1 
cohort) 
654 eligible for analysis. 358 girls and 296 
boys  
63 with incomplete dataset. 
591 eligible for regression analysis. 348 
girls and 243 boys  
Fig. 1 Flowchart of participation
in Fit Futures 1 (TFF1) 2010–
2011 and Fit Futures 2 (TFF2)
2012–2013
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the two-dimensional DXA scans is incomplete, partial correla-
tion was used to adjust for TFF1 height and weight as well as
change in height and weight. We stratified participants into quar-
tiles of aBMD and BMC z-scores and examined the proportions
of participants that remained within quartiles, drifted upwards, or
drifted downwards between TFF1 and TFF2. Furthermore, an
aBMD z-score change variable were computed (Z2 − Z1). To test
whether baseline age, anthropometric traits (height, weight), and
lifestyle factors (PA, alcohol consumption, smoke use, and snuff
use) were associated with positive deviation from tracking (z-
score change >0), we used logistic regression. The reference
categories were no change or downwards drift (z-score change
≤0). Odds ratios (ORs) with 95% confidence intervals (CIs) for
upwards drift during follow-up were calculated. We simulta-
neously adjusted for age, anthropometric measures, lifestyle var-
iables, sexual maturation, and time between measurements. The
influence of other relevant confounders like baseline aBMD z-
score, ethnicity, chronic disease, and medication known to affect
bone health bone and hormonal contraceptive use (girls) were
explored, and purposeful selection was used to select final model
[23]. We evaluated relevant two-way interactions. We fitted
models for FN, TH, and TB separately and ran logistic regression
diagnostics, and assumptions were met. Significance level was
set to p = 0.05 in all analysis, and all procedures were performed
in SPSS version 23.
Results
Descriptives
We included 654 adolescents, 358 girls and 296 boys aged 15 to
17 at baseline in the present analysis (Table 1). Themajoritywere
16 years of age (n = 534), while a small group of 28 participant
were 15 years at baseline. Mean follow-up time was 1.94 years
(SD 0.20). Thirty-two percent of TFF1 participants were lost to
Table 1 Characteristics at baseline survey Fit Futures 1 (TFF1) and follow-up survey Fit Futures 2 (TFF2) 2 years later: continuous variables presented
as mean (standard deviation) and categorical variables in percentage
Girls Boys
TFF1 TFF2 TFF1 TFF2
n n p n n p
Age 358 16.61 (0.387) 358 18.60 (0.40) 296 16.60 (0.367) 296 18.65 (0.35)
Age groups at baseline
15 9 2.5% 19 6.4%
16 296 82.7% 238 80.4%
17 53 14.8% 39 13.2%
Height (cm) 358 165.07 (6.47) 358 165.77 (6.56) <0.001 296 177.25 (6.52) 296 179.08 (6.49) <0.001
Weight (kg) 358 60.42 (10.61) 358 63.11 (11.91) <0.001 296 69.81 (13.68) 296 75.21 (14.64) <0.001
Sexual maturationa
Early/completed 110 31.3% 22 9.1%
Intermediate/underway 168 47.9% 177 72.8%
Late/barely started 73 20.8% 44 18.1%
Ethnicity
White 350 97.8% 291 98.3%
Others 8 2.2% 5 1.7%
Physical activity
Sedentary 43 12.0% 47 13.3% 77 26.3% 81 28.4%
Moderate 141 39.5% 144 40.8% 75 25.6% 60 21.1%
Sports 110 30.8% 110 31.2% 71 24.2% 77 27.0%
Competition 63 17.6% 52 14.7% 70 23.9% 67 23.5%
Smoking (yes) 68 19.0% 102 28.5% <0.001 62 20.9% 114 38.5% <0.001
Snuff use (yes) 108 30.2% 152 42.5% <0.001 108 36.5% 142 48.0% <0.001
Alcohol consumption (yes) 262 73.2% 336 93.9% <0.001 195 65.9% 272 91.9% <0.001
Diseases known to affect boneb (yes) 4 1.1% 5 1.7%
Medication known to affect bonec (yes) 8 2.2% 6 2.0%
Hormonal contraceptive use (yes) 118 33.0%
Estrogen and progestogens 105 29.3%
Progestogens only 13 3.6%
a Sexual maturation in girls: menarche age. Categories are early (<12.5), intermediate (12.5–13.9), and late (>14). Sexual maturation in boys: Puberty
Developmental Scale. Categories are have not begun (<2), barely started (2–2.9), underway (3–3.9), and completed (4)
b Diseases known to affect bone (ICD10): E03 hypothyroidism, E10 diabetes type 1, F50.9 eating disorders, K90.0 celiac disease, and M13 arthritis
cMedication known to affect bone (ATC): D07A plain corticosteroids, H03A thyroid preparations, N03A antiepileptic, R01AD corticosteroids, R03BA
glucocorticoids (inhalants), and H02A corticosteroids for systemic use
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follow-up. Dropout analysis showed statistically significant
higher proportion of boys, smokers, snuff users, and consumers
of alcohol (girls only) among non-responders compared to those
who participated in both surveys.
Changes in bone traits and anthropometry
In the overall study, population aBMD increased significantly
(p < 0.05) at all sites in both sexes. Mean annual percentage
increase for FN, TH, and TB aBMD (g/cm2) was 0.3, 0.5, and
0.8 in girls and 1.5, 1.1, and 2.0 in boys, respectively
(p < 0.05). A similar pattern was present for BMC. When
stratified into age at baseline, mean annual percent change in
aBMD at all skeletal sites decreased successively by increas-
ing age in both sexes (Fig. 2). The differences in annual
aBMD changes between age groups were statistically signifi-
cant (p < 0.05) at most skeletal sites and ages; the exceptions
were changes in TH aBMD between all age groups and FN
aBMD between age 16 and 17 years in boys, as well as chang-
es in FN and TH aBMD between 15- and 16-year-old girls.
Girls 17 years of age at TFF1 had a mean annual percentage
FN aBMD loss of −0.61 (95% CI −0.15, −1.07) and −0.14
(−0.54, 0.27) at the total hip. Average annual percentage BA
change for FN, TH, and TB were 0.01, 0.09, and 2.30 and
0.23, 0.39, and 2.10 for girls and boys, respectively. The av-
erage annual height and weight changes during the follow-up
period were 0.36 cm (95% CI 0.32–0.41) and 1.37 kg (1.11–
1.63) for girls and 0.93 cm (0.83–1.03) and 2.70 kg (2.35–
3.04) for boys, respectively.
Tracking from baseline to follow-up
Correlations between TFF1 and TFF2 z-scores were high in
both sexes at aBMD FN, TH, and TB, Pearson’s r = 0.960,
0.966, and 0.967 for girls and 0.937, 0.955, and 0.946 for
boys, respectively. Calculations of coefficients for BMC,
height, and weight showed similar strong correlations.
Adjusting for TFF1 height and weight or changes in height
and weight using partial correlation did not change the aBMD
results (not shown). Age-stratified coefficients showed weak-
er correlation at all sites for 15-year-old boys, FN 0.884, TH
0.871, and TB 0.853 (N = 19). All correlation coefficients
were statistically significant (p < 0.0001). Overall, 78.2% of
the girls kept their FN aBMD quartile position between
Fig. 2 Mean annual percent change in femoral neck total hip and total body aBMD and BMC for girls and boys stratified by age at Fit Futures 1 (TFF1)
with 95% confidence intervals
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measurements, correspondingly 73% of the boys. The same
stability within quartiles was found at TH and TB, 79.6 and
77.4% for girls and 79.2 and 77.7% for boys, respectively.
Figure 3 illustrates z-score drift between baseline, and
follow-up and shows proportions of participants remaining
in each specific quartile.
Predictors of positive deviation from tracking
Baseline FN, TH, and TB aBMD z-scores had a statistically
significant association with lower odds of positive deviation
from tracking for both girls and boys (Table 2). Later sexual
maturation tended to be associated with higher odds of
Fig. 3 Scatterplot of aBMD z-score for femoral neck (FN), total hip
(TH), and total body (TB) at baseline vs z-score at follow-up with
proportions of participants remaining in baseline quartile. Lines
represent the cutoff for percentiles 25, 50, and 75%. Measurements
outside diagonal quartiles have changed quartile between baseline and
follow-up. Participants were 15–17 years of age at baseline. Boys
n = 296. Girls n = 358
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positive drift at several skeletal sites, with a statistically sig-
nificant association for TB in girls. For boys, baseline body
weight was associated with higher odds of positive deviation
at TH (p = 0.018), and a statistically significant interaction
between age and weight was detected at FN; when stratified
into younger (<16.66 years) and older (≥16.67 years) boys,
the association between baseline weight and higher odds of
positive deviation in FN aBMD was limited to the younger
boys (p = 0.039). There were no statistically significant asso-
ciations between lifestyle factors and higher aBMD z-scores
in boys; smoking only tended to be associated with decreased
odds for higher TH aBMD z-score at follow-up (p = 0.062). In
girls, snuff and alcohol use were associated with significantly
lower odds of higher TH and TB aBMD z-scores, respective-
ly. Also, CHC use was associated with reduced odds of up-
wards drift during follow-up at FN (p = 0.048). Baseline rec-
reational PA level was positively associated with significantly
higher TB aBMD z-score at follow-up in girls; participation in
recreational sports at least 4 h per week and participation in
hard training/sports competitions several times a week were
associated with a fourfold and threefold increase in the odds of
higher TB aBMD, respectively. Data also indicated a more
moderate effect of PA on FN aBMD in girls (p = 0.080;
Table 3).
Discussion
This study presents results from a large population-based co-
hort of adolescents entering young adulthood. Our results in-
dicate that Norwegian adolescents still accumulate bone mass
and increase aBMD between 16 and 18 years of age, although
bone acquisition decreases significantly with age at all skeletal
sites during these 2 years of follow-up. The results also sug-
gest that girls may be reaching an aBMD plateau at femoral
sites between 17 and 19 years of age, even with an indicated
reduction of aBMD at femoral neck around the age of 19
compared to 2 years earlier. Consistent with our hypothesis,
we report that a stable position within quartiles based on
aBMD z-scores is kept over 2 years in late adolescence.
Baseline z-scores were consistently associated with lower
odds of positive deviation from tracking across all skeletal
sites for both sexes. In boys, anthropometric baseline mea-
sures appeared to be associated with upwards drift. In girls,
several lifestyle factors had statistically significant associa-
tions. Particularly, PA tended to be beneficial for TB aBMD.
The decrease in FN aBMD for girls between 17 and
19 years of age is unexpected. However, Berger et al. reported
similar findings with an average decrease of aBMD in girls
around 20 years of age until stabilization and consolidation
[24]. As no specific characteristic in these girls could account
for this development like late menarche or intensive physical
activity, the relationship between BMC and BA and precision
of measurement could explain these findings. According to
Sundberg et al. [25], pubertal bone growth is due to increased
bone size rather than increased density. aBMD will increase
only if BMC increases proportionally more than BA [4].
Elaborative analysis showed that mean FN BA in girls aged
17 years at baseline increased while mean BMC dropped
slightly resulting in lower mean aBMD. The decreasing trend
of bone acquisition with age is similar at all three sites, and
changes in femoral sites seem to drop in advance of total body
aBMD. This is consistent with other longitudinal studies [26,
Table 2 Mean and (standard deviation) of bone traits and time between measurements: areal bone mineral density (aBMD), bone mineral content
(BMC), and bone area (BA) for femoral neck (FN), total hip (TH), and total body (TB) at baseline survey Fit Futures 1 (TFF1) and follow-up survey Fit
Futures 2 (TFF2) 2 years later
Girls Boys
TFF1 TFF2 TFF1 TFF2
n n p n n p
aBMD FN (g/cm2) 358 1.07 (0.13) 357 1.08 (0.13) 0.008 296 1.11 (0.15) 296 1.14 (0.15) <0.001
aBMD TH (g/cm2) 357 1.06 (0.13) 357 1.07 (0.13) <0.001 296 1.12 (0.15) 296 1.14 (0.16) <0.001
aBMD TB (g/cm2) 357 1.14 (0.08) 358 1.16 (0.07) <0.001 296 1.18 (0.10) 296 1.23 (0.09) <0.001
BMC FN (g) 358 4.92 (0.71) 357 4.94 (0.72) <0.001 296 5.99 (0.99) 296 6.19 (0.99) <0.001
BMC TH (g) 357 32.03 (4.84) 357 32.42 (4.95) <0.001 296 40.17 (6.64) 296 41.26 (6.86) <0.001
BMC TB (g) 357 2524.06 (388.27) 358 2600.95 (381.68) <0.001 296 2963.78 (469.83) 296 3200.96 (476.10) <0.001
BA FN (cm2) 358 4.60 (0.34) 357 4.60 (0.34) 0.866 296 5.38 (0.39) 296 5.41 (0.37) 0.003
BATH (cm2) 357 30.15 (2.32) 357 30.22 (2.38) 0.068 296 35.73 (2.47) 296 35.99 (2.51) <0.001
BATB (cm2) 357 2207.37 (233.59) 358 2241.68 (224.95) <0.001 296 2496.46 (240.06) 296 2598.28 (237.87) <0.001
Time between measurements
(years)
358 1.94 (0.20) 296 2.01 (0.23)
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27]. Bachrach et al. found that, for girls, gains in aBMD leveled
off in total hip, spine, and whole body already at the age of 14.1,
15.7, and 16.4, respectively. Boys tended to reach plateau at the
age of 15.7 in total hip and 17.7 in spine and whole body [28].
Differences in statistical analysis used to localize the age of pla-
teau may explain the slightly earlier age indication compared to
our findings. The 2-year developmental difference between boys
and girls was present in our cohort as well. Hormonal status
influences bone development and PBM depends on biological
rather than chronological age [29].
Our tracking results are comparable with other studies [10,
12, 13]. In contrast, Buttazzoni et al. [16] concluded with low
sensitivity for childhood bone mass scans to predict PBM.
Their study included 65 boys and 56 girls with a time frame
of 11 years. With the extensive follow-up period and a mean
baseline age of 8 years, this study is not directly comparable to
ours. Follow-up during PHV is expected to show reduced
correlation, and Kalkwarf et al. reported lower correlations
in younger children than in older [10]. In our cohort, aBMD
tracking for boys became successively stronger as annual
height change reduced gradually between 15 and 17 years of
age at baseline, indicating this link between statural growth
and aBMD tracking (data not shown). The tendency of stron-
ger degree of tracking with cessation of growth strengthens
the notion that measures in our study potentially can predict
adult bone mineral status. The results for participants in the
lowest quartile are of clinical importance and highlight the
great challenge of changing the bone mineral-level trajectory
of this group. Even though this study has a narrow time span,
the fact that a large proportion of adolescents with low bone
mass levels remains low supports the hypothesis that subjects
susceptible to relatively early osteoporosis risk may be detect-
able early in life.
The importance of PBM makes it interesting to explore
modifiable factors with the potential of altering the bone mass
trajectory. Our study suggested that baseline body weight may
influence aBMD at femoral sites in boys, but not in girls. Age
being an effect modifier of weight for boys at FN is biologi-
cally reasonable because bone adaptation to mechanical load-
ing is greater in a growing skeleton and FN is highly exposed
to weight [30]. No associations between lifestyle factors and
positive drift were detected for boys. For girls, associations
were incoherent both in terms of direction, statistical signifi-
cance, and skeletal sites. PA seemed beneficial for TB aBMD,
but we found no clear dose-response effect. This may indicate
that participants reporting to be in the hard training and com-
petition category at baseline were already at the tail of the z-
score distribution as reported byWinther et al. [31]. Sustained
activity level during follow-up and preservation of high z-
score could lead to classification into the reference group no
change or downwards drift for these participants. Previous
studies report tobacco use to have a duration and dose-
dependent negative effect on aBMD, while the impact of
alcohol is more unclear [32–36]. Snuff use and smoking main-
ly prevented subjects from positive deviation in our study,
although not statistically significant at all skeletal sites.
However, changes in exposure variables during follow-up
make the interpretations of associations challenging.
Proportions of smokers, snuff users, and participants consum-
ing alcohol all increased during follow-up (Table 1). The re-
lationship between hormonal contraceptive use and aBMD
development remains controversial. Our results indicated
CHC use to be disadvantageous for the FN and supports ev-
idence suggesting that CHC use is likely to impair acquisition
of optimal PBM [37]. Recent reviews emphasize the need for
randomized controlled trials to confirm these effects [38].
Progestogen-only contraceptives have also been associated
with reduced aBMD when used before the achievement of
PBM [39]. This association was not confirmed in our cohort,
but participants reporting to use progestogen-only contracep-
tives were few. The underlying mechanisms behind the effects
of contraceptives are complex and data on length of use and
dosage are lacking. Winter et al. reported that late sexual mat-
uration was associated with low aBMD levels in TFF1 [31].
The fact that proportions of sexual maturation categories in
our study are comparable with other Norwegian youth cohorts
[40] and that the association between late sexual maturation
and increased odds for positive deviation in this longitudinal
study is consistent suggest that this adverse effect levels out to
some extent. As reported by previous studies [10, 12], base-
line aBMD z-score appears to be highly predictive of future z-
score. The consistent association between high baseline z-
score and reduced odds of positive deviation could be due to
the phenomenon regression towards the mean. Extreme mea-
sures at the tails of the distribution will when repeated tend to
be less extreme and closer to average because of variation
within the individual or measurement error [41].
The longitudinal design and the large representative sample
are among the strengths of the study. The sample has well-
described characteristics, is homogenous in age and ethnicity,
and included both sexes and participants from both rural and
urban regions. We used the same densitometer through both
surveys with continuous validations. A well-established re-
search unit ensured high quality of data acquisition. There
are, however, limitations to be discussed. Firstly, DXA and
aBMD measurements have their limitations. Interpretation of
DXA measures of growing skeletons could be problematic
because it is a two-dimensional measure and size dependent
[42]. aBMD is furthermore only a surrogate measure of bone
strength, and the broad concept of PBM captures other param-
eters like architecture, geometry, and distribution of trabecular
and cortical bone [6]. Secondly, non-participation and loss to
follow-up could be a problem if only the healthy part of the
population chooses to participate. Fourteen percent of the el-
igible population were not invited because we were unable to
get in contact with them due to chronic illness or dropout from
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school. School dropouts tend be associated with an unhealthy
lifestyle [35]. The detected differences in characteristics be-
tween non-responders and participants attending both surveys
may cause bias. A higher proportion of snuff user among non-
responders would make the statistically significant association
between snuff use and lower odds for positive drift for girls an
underestimation. Thirdly, we acknowledge that the follow-up
time of 2 years may be a limitation. Changes over such a short
time period are at risk of being obscured by variability in DXA
measurements. On the other hand, the recommended mini-
mum interval between DXA scans is 6–12 months [42], and
our findings are in accordance with previous reports.
In conclusion, this study corroborates the findings of pre-
vious research exploring the dynamics of bone mineral levels
in adolescence. We report a high degree of tracking of aBMD
levels over 2 years in late adolescence. Because of the short
time span between measurements, a longer follow-up is nec-
essary for definite conclusions on tracking. Baseline aBMD z-
score was the only consistent predictor of deviation from
tracking in both girls and boys. For boys, baseline body
weight tended to be associated with upwards drift in aBMD
z-score at femoral sites. For girls, lifestyle factors such as PA,
snuff use, and consumption of alcohol appeared important, but
not persistently across skeletal sites. Further studies are need-
ed in order to investigate the possible effect of changes in
anthropometrics and lifestyle factors on development of
aBMD in adolescence. Additional follow-up surveys of the
Fit Futures cohort are required to explore further longitudinal
effects.
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